EXPLORING THE UNKNOWN: USE OF SENSITIVITY ANALYSIS TO CHARACTERIZE RESIDUAL UNCERTAINTY IN REAL-WORLD EXTERNAL CONTROL ARM EVIDENCE SUBMITTED TO NICE

被引:0
|
作者
Leahy, T. [1 ]
Keenan, C. [1 ]
Robertshaw, E. [1 ]
Mcstravick, M. [2 ]
Sammon, C. [1 ]
Turner, A. [1 ]
机构
[1] Putnam Associates, London, England
[2] Putnam Associates, Newcastle Upon Tyne, England
关键词
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
P2
引用
收藏
页数:2
相关论文
共 50 条
  • [11] Real-world evidence to support regulatory decision-making for medicines: Considerations for external control arms
    Burcu, Mehmet
    Dreyer, Nancy A.
    Franklin, Jessica M.
    Blum, Michael D.
    Critchlow, Cathy W.
    Perfetto, Eleanor M.
    Zhou, Wei
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 (10) : 1228 - 1235
  • [12] Utilizing Real-World Data to Create an External Control Arm for a Phase 3 Trial of Deucravacitinib for Treatment of Plaque Psoriasis
    Althoff, Amanda G.
    Rasouliyan, Lawrence
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 164 - 165
  • [13] The Evidence REVEAL Study: Exploring the Use of Real-World Evidence and Complex Clinical Trial Design by the European Pharmaceutical Industry
    Varnai, Peter
    Dave, Anoushka
    Farla, Kristine
    Nooijen, Anke
    Petrosova, Liana
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 110 (05) : 1180 - 1189
  • [14] Exploring real-world evidence to uncover unknown drug benefits and support the discovery of new treatment targets for depressive and bipolar disorders
    Teneralli, Rachel E.
    Kern, David M.
    Cepeda, M. Soledad
    Gilbert, James P.
    Drevets, Wayne C.
    JOURNAL OF AFFECTIVE DISORDERS, 2021, 290 : 324 - 333
  • [15] COMPARISON OF THE USE OF REAL-WORLD EVIDENCE FOR CLINICAL EFFECTIVENESS IN HTA PRE- AND POST-INTRODUCTION OF THE NICE FRAMEWORK - AN UPDATE
    Green, R.
    Shrivastava, M.
    Chasimpha, S.
    Mackley, R.
    Teague, R.
    VALUE IN HEALTH, 2024, 27 (06) : S253 - S253
  • [16] APPLICATION OF A NOVEL BAYESIAN DYNAMIC BORROWING APPROACH USING ANONYMIZED FINNISH REAL-WORLD DATA AS AN EXTERNAL CONTROL ARM TO AUGMENT AN INTERNAL CONTROL ARM OF A RANDOMIZED CLINICAL TRIAL
    Potts, J.
    Wang, M. D.
    VALUE IN HEALTH, 2024, 27 (06) : S264 - S264
  • [17] Use of RET inhibitors among patients with advanced NSCLC: A real-world evidence analysis.
    Dawood, Shaheenah S.
    Brzozowski, Kaylen
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [18] Real-world evidence analysis of the follicle- stimulating hormone use in male idiopathic infertility
    Santi, Daniele
    Spaggiari, Giorgia
    Granata, Antonio R. M.
    Simoni, Manuela
    BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2022, 85 : 121 - 133
  • [19] USE OF REAL-WORLD EVIDENCE FOR REIMBURSEMENT IN BRAZILIAN PUBLIC SECTOR: AN ANALYSIS OF SUBMISSIONS IN NEUROLOGY AND RHEUMATOLOGY
    Meirelles, I
    Kano, B.
    Martins, J.
    Kashiura, D.
    Julian, G.
    Lemos, L.
    Lima, P.
    Oesterreicher, B.
    Torres, L.
    VALUE IN HEALTH, 2022, 25 (01) : S180 - S180
  • [20] Exploring uncertainty and use of real-world data in the National Institute for Health and Care Excellence single technology appraisals of targeted cancer therapy
    Kang, Jiyeon
    Cairns, John
    BMC CANCER, 2022, 22 (01)